MENU
KPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kiora Pharmaceuticals (KPRX) Ownership - Who owns Kiora Pharmaceuticals?
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
332 Encinitas Boulevard
Phone
+1 858 224-9600
Employees
12
Web
https://www.kiorapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.83M
P/E Ratio
3.67
Total Cash
24.11M
Projected Growth
N/A
Total Debt
159.02K
Revenue
N/A
Risk (Beta)
-1.32
Dividend Yield
N/A
Total Cash/Share
7.92
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KPRX
Capitalization
8.83M
P/E Ratio
3.67
Risk (Beta)
-1.32
Dividend Yield
N/A
Total Cash
24.1M
Total Cash/Share
7.92
Total Debt
159K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
23.7M
P/B Ratio
0.37
Cash Flow
N/A
Earnings
-4.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
268K
Current Ratio
5.14
Current Revenue Per Employee
1333333.40
Dividends Per Share - Security
N/A
EBITDA
-9.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.52
Shares Held By Institutions
3.96M
Shares Outstanding - Current
3.04M
Total Liabilities
10.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-11.515
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products to treat eye diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
332 Encinitas Boulevard
Phone
+1 858 224-9600
Employees
12
Web
https://www.kiorapharma.com